Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 53.33

-0.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who started this subject	9/7/2003 12:08:07 PM
From: Ian@SI	Read Replies (1) of 52153

Several Biotech/Pharma/Medical Device stories in Barron's... Interview with John Martin, CEO at GILD: online.wsj.com An Editorial Commentary re drug prices and R&D impact during the next 5 years. Requiem for Research Stock prices and profits keep science alive By J.D. KLEINKE THE YEAR IS 2008... : online.wsj.com Heart-Fought Battle J&J seeks to block Boston Scientific's rival stent, but Wall St. doesn't seem to have noticed By BILL ALPERT: online.wsj.com And a more upbeat article on big Pharma... Good Medicine Drug stocks look attractive, especially compared with tech. Time to load up on Pfizer? By ANDREW BARY DRUG STOCKS HISTORICALLY have commanded lofty price/earnings ratios, owing to the industry's impressive record of predictable, double-digit annual profit growth. Yet several major drug stocks, including industry leaders Pfizer and Merck, now carry lower P/Es than the Standard and Poor's 500 index, ... : online.wsj.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next